For following the competition: what moved in each program, several studies read as one move.
- Autologous CD19/CD22 dual-target CAR-T module
- Autologous CD19/CD20 dual-target CAR-T module
- Autologous BCMA/CD19 dual-target CAR-T module
- + 5 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Blastic Plasmacytoid Dendritic Cell Neoplasm to watchlistEvery Monday by email · turn it off any timePro · free during the beta